创新药研发充满荆棘,近期多家药企接连宣布“折戟”

制药网
Dec 18, 2025

创新药被喻为医药行业的“皇冠明珠”,成功上市往往意味着巨额回报与生命希望。但近期多家药企密集宣布研发失败或暂停的消息,再次揭开了这顶“皇冠”下的残酷真相——创新药研发从来都是一条周期漫长、成本高企、失败率惊人的“荆棘之路”。如赛诺菲近日公告称,公司研发的治疗晚期多发性硬化症的药物tolebrutinib在一项针对原发性进展型多发性硬化症的后期试验中,未能延迟患者残疾的进展。其PERSEUS 3期...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10